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Background: Mini-Mental State Examination (MMSE) is one of the most commonly used methods in the
assessment of cognitive mental status. MMSE has been used in hepatology but its usefulness in the evaluation of
hepatic encephalopathy (HE) has never been properly assessed. The aim of the study was to investigate the value
of MMSE in detection of HE in patients with cirrhosis.
Methods: One hundred and one consecutive patients with liver cirrhosis underwent neurological examination,
MMSE and electroencephalography (EEG). Spectral analysis of EEG was done with calculation of mean dominant
frequency (MDF) and relative power of delta, theta, alpha and beta rhythms. Minimal HE was diagnosed in patients
with normal neurological status and alterations in spectral EEG. Statistical analysis included Fisher’s exact and Anova
analysis. Categorical data were compared using Levene’s test for equality of variances. Correlation-coefficient
analysis was performed by the Pearson’s r or Z-test, as needed. Tests performance was assessed by the calculating
the area under the ROC curve (AUC) and evaluating its difference from reference area (AUC=0.5). A p value <0.05
was considered statistically significant.
Results: Overt HE was identified in 49 (48.5%) and minimal HE in 22 (21.8%) patients. Although there were significant
correlations between both severity of liver disease (Child-Pugh classification), overt HE (West-Haven criteria) and
various MMSE items, MDF showed no correlation with any of MMSE items as well as MMSE summary score. MMSE
(score and items) did not discriminate patients without HE and minimal HE. The only significant differences
between patients without HE and with overt HE were seen in respect of MMSE score (p<0.02), orientation to place
(p<0.003), repetition (p<0.01) and complex commands-understanding (p<0.02). Test performance analysis has
shown that MMSE has no value as a prediction method in determining minimal HE and in respect of overt HE has
a sensitivity of 63% and specificity of 52% by a cut-off level at 27.5 points to diagnose overt HE.
Conclusions: In conclusion, although MMSE score and single items are altered in patients with overt HE, MMSE
has no value in the assessment of minimal HE. Because MMSE could be impaired in several cognitive dysfunctions,
more specific test should be used for measuring HE.
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Table 1 Demographic data of study group
Demographic data Study group (n=101)
Age (years, mean ± SD, range) 54.5 ± 11.8 (18–87)
Gender (male/female) 68 (67.3%)/33 (32.7%)














Bilirubin (mg/dl, mean ± SD, range) 3.2 ± 3.6 (0.3-21.2)
INR (mean ± SD, range) 1.3 ± 0.2 (1.0-1.8)
Albumin (mean ± SD, range) 3.6 ± 0.63 (2.2-4.9)
Ammonia (mean ± SD, range) 84.2 ± 98.5 (7.1-805)
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Hepatic encephalopathy (HE) is a serious complication
of liver cirrhosis negatively affecting both health-related
quality of life and survival [1-3]. It comprises a pleth-
ora of neuropsychiatric symptoms ranging from subtle
neurocognitive alterations to severe life-threatening
neurological impairment [4]. Although it is now con-
sidered as a continuum of neurocognitive deterioration
[5], HE is usually divided into minimal and overt HE,
regarding the change in the mental state. A characteristic
feature of minimal HE is lack of a detectable brain dys-
function in the clinical examination, however subclinical
psychomotor slowing and cognition deficits are typically
present in minimal HE and clinically relevant [6-8]. Overt
HE is characterized by various symptoms encompassing
neuromuscular abnormalities, intellectual functions, per-
sonality and consciousness, traditionally graded on four
stages according to West-Haven criteria [3].
Several diagnostic methods were implemented both to
diagnose and to monitor HE, but until now there is no
consensus about the diagnostic standard. Mini-Mental
State Examination (MMSE) has been also used in the
assessment of the severity and in monitoring of HE in
several studies [9-13]. MMSE is a brief questionnaire,
that was introduced by Folsteinet al. in 1975 for the
assessment of cognitive mental status [14]. After minor
subsequent modifications it is currently one of the most
popular methods for the screening of cognitive function
impairment used both in clinical practice and in research in
broad variety of medical conditions [15]. MMSE evaluates
neurocognitive deficits, that are also present in minimal HE
and are forerunners of more severe HE. These are easily
underestimated by a routine examination, therefore the
information drew from the detailed analysis of MMSE
could potentially serve as a well structured and objective
way of identification of changes in mental status in patients
with cirrhosis. Nevertheless the real usefullness of MMSE
in the evaluation of HE has never been properly studied.
Moreover MMSE was until now only interpreted as a total
score, and was not divided into separate items. We
therefore performed a detailed analysis of MMSE items
and investigated the potential value of MMSE in evaluation
of HE in patients with liver cirrhosis.
Methods
Patients
One hundred and one consecutive patients with liver
cirrhosis: 68 (67.3%) males and 33 (32.7%) females, aged
54.5 ± 11.8 years (range 18–87) were enrolled to our study.
Detailed demographic data are shown in Table 1. Included
subjects were both in-patients and out-patients who re-
ceived their treatment at our institution. Included patients
had no history of factors impairing mental status, such as
consumption of psychotropic drugs, active alcohol misuse,neurological (i.e. dementia, epilepsy, alcoholic seizures)
and other than liver disease severe medical problems. Liver
cirrhosis was diagnosed by liver biopsy and/or a typical
appearance of the liver on abdominal ultrasound and/or
computed tomography scan. Blood samples for liver bio-
chemistry and venous ammonia level were collected on the
day of examination. The Child–Pugh score was calculated
to assess the severity of liver disease [16,17]. All patients
underwent detailed neurological examination, MMSE and
closed-eye electroencephalography (EEG) performed by
one experienced neurologist (DK).
MMSE
MMSE consists of several short questions and problems
grouped into 8 items: orientation to time and to place,
registration, attention and calculation, recall, language skills,
repetition and complex commands (i.e. write a sentence
of his own choice, reading a sentence, understanding a
command, copy of pentagons). Each item is scored and
summary score of maximal 30 points is calculated with
higher scores indicating better cognitive performance.
EEG analysis
EEG was recorded for 20 minutes, with eyes closed, in a
condition of relaxed wakefulness, using 18 silver-silver
chloride electrodes placed according to the International
10–20 system (Nervus-Multimedia EEG, Taugagreininghf,
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was Fz. The impedance was kept below 5 kΩ. Each channel
had its own analog-to-digit converter, the resolution was
0,19 uV/digit. Single observer (DK) visually inspected the
traces and classified according to the Parsons- Smith grad-
ing [18] modified by Amodio et al. [19].
Spectral analysis was carried out on the transverse deriv-
ation P3-Pz and P4-Pz in the frequency range of 0,5-30 Hz.
Pre-selected 80–100 s periods of artifact-free recording,
split into 5 s epochs were analyzed by applying Fast Fourier
Transformation. Mean dominant frequency (MDF) was
calculated, the mean values were used. The relative power
of delta (0.5-4.0 Hz), theta (4.0-8.0 Hz), alpha (8.0-13.0 Hz)
and beta (13.0-30.0 Hz) rhythms were calculated. EEG
alterations associated with HE were then graded using
the thresholds proposed by Amodio et al. [20]. Grade 1 by
MDF >6.8 and Theta% ≥35%; grade 2 by MDF ≤ 6.8 Hz
and Delta% < 49%; grade 3 MDF ≤ 6.8 and Delta% ≥49.
Diagnosis of HE
Clinical evaluation of overt HE was performed by an
experienced neurologist (DK) and comprised of a detailed,
comprehensive neurological examination according to
West-Haven criteria. Following symptoms were particularly
noted: psychomotor slowing, impaired performance of
arithmetic, disorientation for time and place, inappropriate
behavior, extrapyramidal signs, asterixis, ataxia etc. Patients
were also reviewed in respect of neuropsychiatric disorders
(e.g. epilepsia, alcoholic seizures) and circadian rhythm
disturbance. Overt HE was diagnosed in patients, in
whom typical abnormalities were present independent
from EEG results. West-Haven criteria were applied for the
assessment of the severity of overt HE [3,21]. Minimal
HE was considered in patients with unaltered neuro-
logical status but with alterations in spectral analysis of
EEG (i.e. grade ≥ 1 according to the system proposed by
Amodio P. et al.) [20].
Statistics
Patient measures are reported as means ± standard de-
viation (SD). All data were analyzed using Stat-View-5
Software (SAS Institute, Cary, NC, US) and included
Fisher’s exact and Anova analysis. Categorical data were
compared using Levene’s test for equality of variances.
Correlation-coefficient analysis was performed by the
Pearson’s r or Z-test, as needed. Tests performance was
assessed by the calculating the area under the ROC
curve (AUC) and evaluating its difference from refer-
ence area (AUC=0.5). A p value <0.05 was considered
statistically significant.
Ethics
Written informed consent was obtained from each patient
included in the study. The study protocol was approvedby the appropriate ethics committee of Pomeranian
Medical University, Szczecin, Poland and conforms to the
ethical guidelines of the 1975 Declaration of Helsinki
(6th revision, 2008).
Results
MMSE results in the study group
All included patients, who completed MMSE performed
three items: registration, language skills and complex
command - reading a sentence fully correctly. These items
were not further analyzed. MMSE (summary score and
most of the items) were independent from age and gender
of the patients. Only results for a complex command - copy
of pentagons item were more altered in older patients
(p<0.02, CI95% = −0.430 - -0.053). Moreover males had
significantly better results in respect of a complex com-
mand - write a sentence than females (mean: 0.97 ± 0.37
vs 0.84 ± 0.175 points, p<0.03).
There were significant correlations between severity of
liver disease (Child-Pugh classification) and MMSE sum-
mary score (r = −0.420, p<0.0001, CI 95% = −0.573 - -0.239)
and several MMSE items: orientation to time (r = −0.476,
p<0.0001, CI95% = −0.618 - -0.303), orientation to
place (r = −0.391, p<0.0001, CI95% = −0.549 - -0.206)
and complex commands: understanding a command
(r = −0.295, p<0.005, CI95% = −0.468 - -0.099), write a
sentence (r = −0.389, p<0.0001, CI95% = −0.547 - -0.203)
and copy of pentagons (r = −0.353, p<0.0005, CI95% = −
0.517 - -0.163). Patients in Child-Pugh class A and B
had better results of MMSE (summary score and most
of the items) than patients in Child-Pugh class C. In
contrast patients in Child-Pugh class A and B achieved
similar results in most of the MMSE items. These results
are summarized in Table 2.
Venous ammonia concentration did not correlate with
MMSE summary score and all items except the repetition
item (r=−0.324, p<0.002, CI95%=−0.499 - -0.125).
MMSE results in patients with HE
Neurological examination identified 49 (48.5%) patients
with overt HE: 26 (25.7%) in grade 1, 16 (15.8%) in grade
2 and 7 (6.9%) in grade 3 according to West-Haven cri-
teria. In 22 (21.8%) subjects without clinical symptoms
of HE, minimal HE was diagnosed based on spectral
analysis of EEG.
MMSE (score and items) did not discriminate patients
without HE and minimal HE, however there were signifi-
cant differences between patients without HE and with
overt HE in respect of MMSE summary score (p<0.02),
orientation to place (p<0.003), repetition (p<0.01) and
complex commands - understanding (p<0.02) (Table 3).
In patients with more severe overt HE according to
West-Haven criteria we observed reduction in most of
MMSE scores, which reached a statistical significance
Table 2 MMSE results dependent of severity of liver disease (Child-Pugh classification)
MMSE categories Class A (n=44) Class B (n=35) Class C (n=22) A vsB A vs C B vs C
MMSE summaryscore 27.6 ± 1.9 27.0 ± 2.0 24.8 ± 4.8 ns p<0.0005 p<0.01
Orientation to time 5.0 ± 0.2 4.7 ± 0.8 4.2 ± 0.9 p<0.05 p<0.0001 p<0.03
Orientation to place 4.9 ± 0.2 4.8 ± 0.4 4.4 ± 0.7 ns p<0.0001 p<0.001
Attention and calculation 3.8 ± 1.4 3.7 ± 1.2 3.5 ± 1.9 ns ns ns
Recall 2.2 ± 0.9 2.4 ± 0.7 1.9 ± 0.8 ns ns p<0.05
Repetition 0.8 ± 0.4 0.8 ± 0.4 0.7 ± 0.5 ns ns ns
Complex commands (Understanding) 2.9 ± 0.3 2.8 ± 0.5 2.4 ± 1.0 ns p<0.01 p<0.03
Complex commands (Write a sentence) 1.0 ± 0.0 0.9 ± 0.2 0.8 ± 0.4 ns p<0.001 p<0.02
Complex commands (Copy of pentagons) 1.1 ± 0.6 0.9 ± 0.3 0.6 ± 0.5 ns p<0.002 ns
MMSE Mini-Mental State Examination.
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a complex command - write a sentence. MMSE summary
score was reduced in patients with grade 3 of overt HE in
comparison to patients with grade 1 HE (Table 4).
Test performance analysis has shown that MMSE has
no value as a prediction method in determining minimal
HE (AUC = 0.43, p = 0.317, CI95%= 0.295 – 0.561).
Although AUC analysis reached the statistical signifi-
cance in respect of overt HE (AUC = 0.64, p = 0.018,
CI95% = 0.528 – 0.752), and by a cut-off level at 27.5
points MMSE summary score had a sensitivity of 63%
and specificity of 52% to diagnose overt HE.
MDF
Mean MDF in study group was 7.2±2.3 Hz (range 2.3 -
13.2 Hz). MDF values were independent from subjects’
age, however were lower in males than females (mean
MDF 6.7 ± 2.2 Hz vs 8.2 ± 2.4 Hz respectively, p<0.003)
Although MDF correlated significantly with severity of liver
disease (i.e. Child-Pugh classification, r = −0.373, p=0.0001,
CI95% = −0.531 - -0.191) and HE (i.e. West-Haven classifi-
cation, r = −0.337, p=0.0005, CI95% = −0.5 - -0.152), MDF
values showed no correlation with any of MMSE items as





MMSE summaryscore 27.7 ± 1.8 27.5 ± 2.0
Orientation to time 4.8 ± 0.8 4.9 ± 0.3
Orientation to place 4.7 ± 0.2 4.9 ± 0.2
Attention and calculation 3.7 ± 1.4 3.8 ± 1.5
Recall 2.4 ± 0.6 2.1 ± 0.9
Repetition 0.9 ± 0.3 0.8 ± 0.4
Complex commands (Understanding) 2.9 ± 0.3 2.9 ± 0.2
Complex commands (Write a sentence) 1.0 ± 0.2 0.9 ± 0.2
Complex commands (Copy of pentagons) 1.0 ± 0.2 1.1 ± 0.9
MMSE Mini-Mental State Examination, HE hepatic encephalopathy.Discussion
The appropriate diagnosis of HE causes several problems.
After exclusion of other causes of mental impairment, a
careful clinical examination is usually sufficient for the
diagnosis of overt, mainly more advanced stages of HE
(grade 3 and grade 4 i.e. coma). However less advanced
overt HE require a detailed neuropsychological evaluation.
Moreover, for detection of minimal HE a clinical examin-
ation has a little value because of the lack of clear manifes-
tations, and an additional more sensitive diagnostic tool is
in this case necessary. However, until now no method is
available that can discriminate the specific stages of HE
objectively through the entire spectrum of minimal and
overt HE [4]. The West-Haven grading system, which
classifies HE into categories, remains criticized because of
its intense subjectivity and low intra- and inter-observer
reliability [5,22]. Therefore several other more objective
diagnostic tools (e.g. neuroimaging, neurophysiological
methods or psychomotor tests), were implemented to
diagnose both minimal and overt HE, but there is still an
ongoing debate which of them should be a diagnostic
standard [23-25]. In several studies spectral analysis of
EEG has been proven to be a valuable, sensitive and obser-










25.9 ± 3.7 ns p<0.02 p<0.05
4.6 ± 0.9 ns ns ns
4.6 ± 0.6 ns p<0.003 p<0.01
3.6 ± 1.6 ns ns ns
2.1 ± 0.9 ns ns ns
0.7 ± 0.5 ns p<0.01 ns
2.6 ± 0.8 ns p<0.02 p<0.02
0.9 ± 0.3 ns ns ns
0.8 ± 0.4 ns ns p<0.01
Table 4 MMSE results in patients with overt HE according to West-Haven criteria
MMSE categories Grade 1 (n=26) Grade 2 (n=16) Grade 3 (n=7) Grade 1 vs2 Grade 1 vs 3 Grade 2 vs 3
MMSE summary score 26.8 ± 2.7 25.4 ± 3.9 23.7 ± 5.6 ns p<0.02 ns
Orientation to time 4.7 ± 0.6 4.4 ± 0.9 4.4 ± 1.1 ns ns ns
Orientation to place 4.8 ± 0.4 4.4 ± 0.8 4.4 ± 0.8 p<0.02 p<0.05 ns
Attention and calculation 4.0 ± 1.2 3.7 ± 1.6 2.1 ± 1.9 ns p<0.003 p<0.02
Recall 2.2 ± 0.8 1.9 ± 0.9 1.9 ± 0.9 ns ns ns
Repetition 0.7 ± 0.5 0.6 ± 0.5 0.9 ± 0.4 ns ns ns
Complex commands (Understanding) 2.5 ± 0.7 2.6 ± 0.9 2.5 ± 1.1 ns ns ns
Complex commands (Write a sentence) 1.0 ± 0.2 0.8 ± 0.4 0.9 ± 0.4 p<0.05 ns ns
Complex commands (Copy of pentagons) 0.8 ± 0.4 0.7 ± 0.5 0.6 ± 0.5 ns ns ns
MMSE Mini-Mental State Examination, HE hepatic encephalopathy.
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it in our study as well. However the EEG detects cortical
neuronal activity and may not ideally reflect a wide variety
of neurophysiological events seen in HE [24]. Moreover it
is not broadly implemented in a daily practice because of
its limited availability and the need of an experienced
personnel to appropriate interpretation of the obtained
electroencephalograms. Therefore there is still a need to
develop screening tests for a clinical routine and for a
research in studying patients with liver cirrhosis, which
will cover a whole spectrum of pathophysiological spectrum
of the phenomenon.
Neuropsychological diagnostic tools show a number of
practical advantages making them potent candidates for
the common use in HE assessment [27,28]. Generally
they are simple to perform, not time-consuming can be
used in the out-patient clinic. For this purpose both single
paper-pencil tests (such as the block design test, the
trail making test and the digit symbol test) as well as
standardized batteries (i. a. the Repeatable Battery for
the Assessment of Neuropsychological Status, the Wechsler
Adult Intelligence Scale—Revised, the Auditory Verbal
Learning, the Everyday Memory Questionnaire) have been
implemented [29-35]. The complex tools have a superior
value in comparison to single modalities because they cover
a broad spectrum of neurocognitive deficits. However
among plenty of these tests only the Psychometric Hepatic
Encephalopathy Score (PHES) was especially constructed
for detecting minimal HE [36]. Others have a great import-
ance in the diagnosis of cognitive alteration in elderly or
neuropsychiatric disorders, in the estimation of the effect of
psychoactive drugs or to measure intelligence, but their
value in the field of HE remains to be established.
MMSE is one of above mentioned complex neuropsycho-
logical tools, that was also occasionally used for identifica-
tion patients with HE in clinical trials [9-13] and for several
reasons could serve as a potential screening test for this
purpose. MMSE assesses cognitive abilities: orientation
(spatial and time), attention, concentration, calculation,immediate and short-term memory, visuo-spatial orienta-
tion, praxis and language skills [14]. Some of these func-
tions are also altered in cirrhotic patients in the course of
minimal HE and in stages 1 and 2 overt HE according to
West-Haven criteria, long before neurocognitive decline is
obvious and clinically easy to detect [4].
Indeed our study clearly shows that MMSE (summary
scores and most of the items) is altered in patients with
more advanced liver disease measured by Child-Pugh
classification. Likewise we observed an increasing reduction
of the most of MMSE items in patients with overt HE.
However these differences reached the statistical signifi-
cance only in few items and mostly in more advanced
stages of overt HE (i.e. in grade 2 and 3) and the numeric
difference between MMSE scores was small and unlikely to
be clinically useful. These included orientation to place,
attention and calculation and complex command - writing
a sentence of own choice. Moreover the test performance
analysis has shown that MMSE summary score has low
both specificity and sensitivity in detection of overt HE.
Furthermore MMSE summary score and all items did not
differentiate patients with minimal HE from those without
any signs of HE (i.e. with normal neurological state and
without alteration seen in spectral EEG) and did not correl-
ate with MDF values. These observations clearly shows that
MMSE should not be considered an appropriate tool for
detection of minimal HE and in overt HE in stage 1 and 2
according to West-Haven classification. Although in our
study MMSE was altered in patients with stage 3 of overt
HE, but this can be detect clinically and generally requires
no additional method.
All included into our analysis subjects performed three
items: registration, language skills and complex command -
reading a sentence fully correctly. These observations can
be explained by the heterogeneous nature of HE and by
fact that cognitive functions are selectively compromised
in this disorder [37,38]. While several cognitive functions
are altered very early in the natural course of the disorder
(i.e. attention, visuo-spatial orientation, psychomotor speed),
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(disorientation to place, lethargy, somnolence). On the
other hand some intellectual functions such as language
skills, long-term memory and intelligence are generally
unaffected, even in patients at higher stages of HE [8,39].
Conclusion
In conclusion, although HE is a disorder that affects
the mental status and causes a decrease in the MMSE,
our study strongly suggests that this modality is not an
appropriate tool in defining an encephalopathy-related
status of patients with cirrhosis and should not be used
for this purpose in clinical trials. In view of the complex
nature of HE there is still a need to develop more specific
test for objective measuring through the entire spectrum
of this phenomenon.
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